2025 Q4
2025-11-21
Scott Gottlieb, M.D. Appointed to UnitedHealth Group Board of Directors
View Filing →
2025-11-13
Amended and Restated Bylaws of UnitedHealth Group Incorporated
effective November 6, 2025
View Filing →
2025-11-07
Senior leaders to respond to questions at UBS Global Healthcare Conference
View Filing →
2025-10-28
Q3 2025 Earnings Released
Revenue and EPS not disclosed in the filing, but mentioned as 'third quarter 2025 results'
View Filing →
2025 Q3
2025-09-08
Investor Meetings & 2025 EPS Guidance Reaffirmed
Reaffirmed 2025 adjusted EPS outlook, Amedisys acquisition closed Aug 2025
View Filing →
2025-08-20
Board Governance Restructuring
New Public Responsibility Committee created, McNabb appointed Lead Independent Director
View Filing →
2025-07-31
CFO Change
Wayne DeVeydt appointed CFO effective Sept 2, replacing John Rex
View Filing →
2025-07-29
Q2 2025 Earnings
Second quarter 2025 results announced
View Filing →
2025-07-24
DOJ Investigation
Criminal and civil DOJ investigation into Medicare program participation
View Filing →
2025 Q2
2025-06-20
Debt Offering
$3B notes issued across 4 tranches, rates 4.4%-5.95%
View Filing →
2025-06-04
Annual Shareholder Meeting & CEO Equity Cancellation
Former CEO Andrew Witty's performance RSUs cancelled upon retirement
View Filing →
2025-05-21
Director Andrew Witty Resigned
Andrew Witty resignation effective May 20, 2025
View Filing →
2025-05-14
CEO Change - Witty Out, Hemsley In
Andrew Witty stepped down, Steve Hemsley appointed CEO with $60M equity award
View Filing →
2025-04-29
Executive Reshuffling
Heather Cianfrocco moves to EVP Governance/Compliance, Patrick Conway becomes Optum CEO
View Filing →
2025-04-17
Q1 2025 Earnings
First quarter 2025 results announced
View Filing →
2025 Q1
2025-01-16
Q4 2024 Earnings
Q4 and full year 2024 results announced
View Filing →
2024 Q4
2024-12-04
CEO Death
Brian Thompson, CEO of UnitedHealthcare, passed away
View Filing →
2024-12-03
2025 Financial Outlook
2024 outlook update and initial 2025 projections announced
View Filing →
2024-11-26
Investor Conference Announcement
Annual investor conference Dec 4, 2024 at 8:00 AM EST in NYC
View Filing →
2024-10-15
Q3 2024 Earnings
Third quarter 2024 results announced
View Filing →
2024 Q3
2024-07-25
Debt Offering
$12B multi-tranche notes, rates 4.75%-5.75%
View Filing →
2024-07-16
Q2 2024 Earnings
Second quarter 2024 results announced
View Filing →
2024 Q2
2024-06-07
Annual Shareholder Meeting
All 10 directors elected, executive compensation approved
View Filing →
2024 Q1